{
  "docId": "019dd923-5fec-763b-95cf-69b322a96f02",
  "docSlug": "xGWB9GQTbCGJgy3pFbHe",
  "documentTitle": "The 24-slide presentation a first-time CEO used to raise $120 million to cure blindness",
  "authorId": "Pitchdecks",
  "authorName": "Aurion Biotech",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 23,
  "pageCount": 24,
  "prevPage": 22,
  "nextPage": 24,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 6,
  "notes": null,
  "elementsJson": [
    "headline_text",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fec-763b-95cf-69b322a96f02/23",
  "deckHref": "/decks/019dd923-5fec-763b-95cf-69b322a96f02",
  "deckJsonHref": "/decks/019dd923-5fec-763b-95cf-69b322a96f02.json",
  "deckAnchorHref": "/decks/019dd923-5fec-763b-95cf-69b322a96f02#slide-23",
  "components": [
    {
      "bbox": {
        "h": 0.14,
        "w": 0.92,
        "x": 0.04,
        "y": 0.61
      },
      "kind": "list",
      "text": "Leverageable Platform; First indication: severe corneal endothelial disease; Additional opportunities: glaucoma, ocular surface disease, AMD",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "02fe41b0-4300-42f3-bc41-87f993b3f61d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.14,
        "w": 0.92,
        "x": 0.04,
        "y": 0.75
      },
      "kind": "list",
      "text": "Deep Industry Experience; Management: Novartis, Glaukos, Alcon, Biogen, Bausch & Lomb, AcuFocus, CorneaGen, Dendreon; Investors: Flying-L-Partners, Falcon Vision (KKR), Petrichor, Visionary Ventures",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1b7acbd4-aff3-41a0-b5cb-2d39e66c5c19",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.14,
        "w": 0.92,
        "x": 0.04,
        "y": 0.47
      },
      "kind": "list",
      "text": "Well-Defined Regulatory Pathway; Japan: NDA submission 2H 2022; US: IND submission 2H 2022",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "263dbbed-53a3-46cc-82cb-08e9fff39f24",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.14,
        "w": 0.92,
        "x": 0.04,
        "y": 0.19
      },
      "kind": "list",
      "text": "Corneal Endothelial Disease: $4.75B Market; 16M people US/EU/Japan, but few are treated (<70,000 / year); Barriers: limited organ supply, complex surgery, economic disincentives",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "46325397-d4b1-4243-8992-38e0a8ea7eb8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.14,
        "w": 0.92,
        "x": 0.04,
        "y": 0.33
      },
      "kind": "list",
      "text": "Clinical Validation: 100+ Patients Treated; Demonstrated efficacy, safety and durability (incl. 5-year follow-up data); Injectable procedure: potential to expand treatment paradigm",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bf5c608b-d571-40ee-810e-f2457cfb54aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "TAM: $4.75B",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-d9f0-76ee-8f9e-129b0e56e946",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.35,
        "x": 0.04,
        "y": 0.1
      },
      "kind": "title",
      "text": "Investment Highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9740eed0-8714-4e3c-bcbf-d24b75969174",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}